Hematologist/Oncologist Muthu Veeraputhiran, M.D., Joins UAMS

By Susan Van Dusen

Veeraputhiran is an assistant professor of medicine in the UAMS College of Medicine Division of Hematology/Oncology. He earned his medical degree at Stanley Medical College in Madras, India, and master’s degree in public health at University of Oklahoma Health Sciences Center in Oklahoma City.

After completing his residency in internal medicine at Temple University affiliate Abington Memorial Hospital in Abington, Pennsylvania, Veeraputhiran completed fellowships in hematology/oncology at Karmanos Cancer Institute in Detroit and bone marrow transplantation at Stanford University in Stanford, California, in addition to a fellowship in transfusion medicine at UAMS. He previously served as a physician at the UAMS Myeloma Institute and at Saint Francis Hospital in Tulsa, Oklahoma.

UAMS is the state’s only health sciences university, with colleges of Medicine, Nursing, Pharmacy, Health Professions and Public Health; a graduate school; a hospital; a main campus in Little Rock; a Northwest Arkansas regional campus in Fayetteville; a statewide network of regional campuses; and eight institutes: the Winthrop P. Rockefeller Cancer Institute, Jackson T. Stephens Spine & Neurosciences Institute, Harvey & Bernice Jones Eye Institute, Psychiatric Research Institute, Donald W. Reynolds Institute on Aging, Translational Research Institute, Institute for Digital Health & Innovation and the Institute for Community Health Innovation. UAMS includes UAMS Health, a statewide health system that encompasses all of UAMS’ clinical enterprise. UAMS is the only adult Level 1 trauma center in the state. UAMS has 3,275 students, 890 medical residents and fellows, and five dental residents. It is the state’s largest public employer with more than 12,000 employees, including 1,200 physicians who provide care to patients at UAMS, its regional campuses, Arkansas Children’s, the VA Medical Center and Baptist Health. Visit www.uams.edu or uamshealth.com. Find us on Facebook, X (formerly Twitter), YouTube or Instagram.

###